Zoster Vaccine Live Dosage

Medically reviewed on January 29, 2018.

Usual Adult Dose for Herpes Zoster - Prophylaxis

0.65 mL subcutaneously in the deltoid once

Comments: Do not give IV or intramuscularly.

Use: Prevention of herpes zoster (shingles) in individuals 50 years of age and older.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 50 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Administer immediately after reconstitution.
-Discard reconstituted vaccine if not used within 30 minutes.
-Do not freeze reconstituted vaccine.

Storage requirements: The manufacturer product information should be consulted.

General:
-The U.S. Department of Health and Human Services has established a Vaccine Adverse Event Reporting System (VAERS) to accept all reports of suspected adverse events after the administration of any vaccine.
-For information or to report online go to www.vaers.hhs.gov.

Patient advice:
-Question the patient about reactions to previous vaccines.
-Inform patient of the benefits and risks, including the potential risk of transmitting the vaccine virus to susceptible individuals, such as immunosuppressed or immunodeficient individuals or pregnant women who have not had chickenpox.
-Instruct patient to report any adverse reactions or any symptoms of concern to their healthcare professional.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer